BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2624008)

  • 1. [Detection of steroid hormone receptors in patients with mastopathies and fibroadenomas].
    Meissner J; Kasch R; Splitt G; Gerber B; Rhode E
    Zentralbl Gynakol; 1989; 111(23):1562-6. PubMed ID: 2624008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Content of 17 beta éstradiol, progesterone and glucocorticoid receptors in patients with benign breast diseases].
    Bassalyk LS; Kuz'mina ZV; Murav'eva NI; Smirnova KD; Vishniakova VV
    Vopr Onkol; 1982; 28(7):3-6. PubMed ID: 7101825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer].
    Remmele W; Schicketanz KH
    Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846
    [No Abstract]   [Full Text] [Related]  

  • 4. [Steroid hormone receptors in the normal breast and in benign mastopathies].
    Kouyoumdjian JC; Feuilhade F; Pinaudeau Y; Rymer JC
    Bull Cancer; 1986; 73(2):120-3. PubMed ID: 3730631
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quantitative determination of steroid hormone receptors in breast cancer tissue outside tumor centers].
    Prechtel D; Prechtel K
    Pathologe; 1993 Jan; 14(1):16-20. PubMed ID: 8451222
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunohistochemical detection of the estrogen receptor in benign tumors of the breast and in forms of mastopathy].
    Köhler G; Bässler R
    Pathologe; 1987 Nov; 8(6):325-33. PubMed ID: 3321027
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunohistochemical analysis of estrogen and progesterone receptors in benign breast diseases.
    Tóth J; De Sombre ER; Greene GL
    Zentralbl Pathol; 1991; 137(3):227-32. PubMed ID: 1931896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone receptors in fibroadenomas of the breast].
    Martin P; Seradour B; Laffargue F; Piana L; Serment H
    J Gynecol Obstet Biol Reprod (Paris); 1977 Dec; 6(8):1071-6. PubMed ID: 608925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell kinetic investigations in fibrocystic mastopathies and invasive breast carcinomas].
    Kunz J
    Acta Histochem Suppl; 1990; 39():175-9. PubMed ID: 2080259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical detection of estrogen and progesterone receptors in paraffin sections].
    Snijders M; Theunissen P; Debets-Te Baerts M; Koudstaal J
    Pathologe; 1990 Jul; 11(4):236-9. PubMed ID: 2204912
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thermolabile characteristics of steroid hormone receptors in breast cancer].
    Merkle E; Bähr I; Tulusan AH; Lang N
    Geburtshilfe Frauenheilkd; 1991 Mar; 51(3):182-5. PubMed ID: 2055391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer].
    von Minckwitz G; Kaufmann M
    Gynakologe; 1993 Apr; 26(2):100-6. PubMed ID: 8508979
    [No Abstract]   [Full Text] [Related]  

  • 14. [Demonstration of estradiol and progesterone receptors in histological preparations].
    Fetissof F; Lansac J; Arbeille-Brassart B
    Ann Anat Pathol (Paris); 1980; 25(3):201-16. PubMed ID: 7015929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
    Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of the receptor content and growth fraction of breast cancers and their axillary lymph node metastases].
    Fleige B; Pickartz H; Stein H
    Pathologe; 1989 Jan; 10(1):12-5. PubMed ID: 2646629
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ductal carcinoma in situ: steroid receptors and proliferation kinetics].
    Ronay G; Sponsel N; Tulusan AH
    Pathologe; 1990 Nov; 11(6):327-31. PubMed ID: 1963219
    [No Abstract]   [Full Text] [Related]  

  • 18. Estradiol and progesterone receptors in human breast tumours.
    Duffy MJ
    Ir Med J; 1980 Aug; 73(8):311-2. PubMed ID: 7451103
    [No Abstract]   [Full Text] [Related]  

  • 19. [Carcinoma arising within mammary fibroadenomas. A study of six patients].
    Tissier F; De Roquancourt A; Astier B; Espie M; Clot P; Marty M; Janin A
    Ann Pathol; 2000 Mar; 20(2):110-4. PubMed ID: 10740004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between morphology and steroid receptors in breast cancer].
    Hanselmann R; Genton CY
    Pathologe; 1983 Jan; 4(1):17-23. PubMed ID: 6844281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.